The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
The National Institutes of Health (NIH), a government organization that focuses largely on biomedical research and supplying ...
Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical ...
Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.
Sweeping layoffs, funding freezes and executive orders have provoked outcry among federal researchers and their university partners, who fear that science itself is under siege.
A long-standing body of research demonstrates that students who have more effective teachers learn more over the school year, ...
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
In the second phase of the research, the team validated the accuracy and universality of the technology through clinical studies involving 200 patients with diabetes and 30 healthy individuals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback